Free Trial
NASDAQ:IVF

INVO Fertility (IVF) Stock Price, News & Analysis

$1.65 -0.03 (-1.79%)
As of 04:00 PM Eastern

About INVO Fertility Stock (NASDAQ:IVF)

Key Stats

Today's Range
$1.59
$1.72
50-Day Range
N/A
52-Week Range
$1.38
$17.04
Volume
154,257 shs
Average Volume
1.42 million shs
Market Capitalization
$3.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NAYA Biosciences (NASDAQ: NAYA) is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and fertility. Our hub & spoke model harnesses the shared resources of a parent company and agility of lean strategic franchises, enabling efficient acquisition, development, and partnering of assets as well as optimized return on investment by combining the upside of innovative clinical-stage therapeutics with scalable, profitable commercial revenues. NAYA’s expanding portfolio of assets currently includes NY-303, a GPC3 and NKp46 targeting bispecific antibody for the treatment of hepatocellular carcinoma (HCC) with a unique mode of action targeting non-responders to the current immunotherapy standard of care (approximately 70% of the current treatable market) cleared to enroll patients in a Phase I/II monotherapy trial in early 2025, NY-338, a CD38 and NKp46 targeting bispecific antibody for the treatment of multiple myeloma and autoimmune diseases with a differentiated safety and efficacy profile, and INVOcell®, an FDA-approved fertility device which has demonstrated comparable success rates to traditional In Vitro Fertilization (IVF).

Receive IVF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for INVO Fertility and its competitors with MarketBeat's FREE daily newsletter.

IVF Stock News Headlines

See More Headlines

IVF Stock Analysis - Frequently Asked Questions

INVO Fertility's stock was trading at $2.18 at the beginning of 2025. Since then, IVF shares have decreased by 26.6% and is now trading at $1.60.
View the best growth stocks for 2025 here
.

INVO Fertility, Inc (NASDAQ:IVF) announced its quarterly earnings data on Tuesday, May, 20th. The company reported ($12.53) earnings per share (EPS) for the quarter. The business earned $1.64 million during the quarter.

Shares of IVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/20/2025
Today
5/27/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical, Medical, And Dental Instruments And Supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:IVF
Web
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$6.59 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$3.63 million
Optionable
N/A
Beta
2.24
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:IVF) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners